[PDF][PDF] Simplified measurement of deoxyglucose utilization rate

GJ Hunter, LM Hamberg, NM Alpert… - Journal of Nuclear …, 1996 - Soc Nuclear Med
Conclusion: These results indicate that the observed tumor tissue uptake of 18FDG,
corrected for blood 18FDGactivity and glucose concentration, can reliably predict glucose …

Procedure guideline for tumor imaging with 18F-FDG PET/CT 1.0

D Delbeke, RE Coleman, MJ Guiberteau… - Journal of nuclear …, 2006 - Soc Nuclear Med
PET is a tomographic scintigraphic technique in which a computer-generated image of local
radioactive tracer distribution in tissues is produced through the detection of annihilation …

[CITATION][C] Quantitating tumor glucose metabolism with FDG and PET

RA Hawkins, Y Choi, SC Huang, C Messa… - Journal of Nuclear …, 1992 - Soc Nuclear Med
The rate constants K* 1and k* 2refer to forward and reverse capillary trans port of FDG, while
k* 3 and k* 4 refer to phosphorylation of FDG and de phosphorylation of FDG-6-P04, re …

A PET study of 18FDG uptake in soft tissue masses

MA Lodge, JD Lucas, PK Marsden, BF Cronin… - European journal of …, 1999 - Springer
A study was performed with the aim of investigating some of the methodological factors
affecting the ability of quantitative 2-[18 F]-fluoro-2-deoxy-d-glucose (FDG) positron emission …

The rate-limiting step for tumor [18F] fluoro-2-deoxy-D-glucose (FDG) incorporation

TAD Smith - Nuclear medicine and biology, 2001 - Elsevier
The enhanced rate of glucose utilization by tumor cells has been exploited in the imaging of
tumors using the radiolabelled glucose analogue fluoro-2-deoxy-D-glucose (FDG)[1], which …

Impact of blood glucose, diabetes, insulin, and obesity on standardized uptake values in tumors and healthy organs on 18F-FDG PET/CT

KA Büsing, SO Schönberg, J Brade… - Nuclear medicine and …, 2013 - Elsevier
INTRODUCTION: Chronically altered glucose metabolism interferes with 18F-FDG uptake in
malignant tissue and healthy organs and may therefore lower tumor detection in 18F-FDG …

[18F] fluorodeoxyglucose uptake in tumors: kinetic vs. steady-state methods with reference to plasma insulin

H Minn, S Leskinen-Kallio, P Lindholm… - Journal of computer …, 1993 - journals.lww.com
Abstract [18 F] Fluorodeoxyglucose (FDG) uptake in noncerebral tumors is commonly
reported as tissue radioactivity concentration normalized to injected dose and body weight …

Impact of intravenous insulin on 18F-FDG PET in diabetic cancer patients

FN Roy, S Beaulieu, L Boucher… - Journal of Nuclear …, 2009 - Soc Nuclear Med
The aims of this study were to evaluate the effectiveness of a standardized insulin protocol in
reducing glycemia, review 18F-FDG biodistribution with such a protocol, and assess its …

[PDF][PDF] FDG-PET in oncology: there's more to it than looking at pictures

AJ Fischman, NM Alpert - Journal of Nuclear Medicine, 1993 - Soc Nuclear Med
When plateau concentrations of FDG are achieved in tissues with low con centration of
glucose-6-phosphatase, images oftotal †8Fradioactivity reflect relative rates of glycolysis …

Clinical applications of 18F-FDG in oncology

HA Nabi, JM Zubeldia - Journal of nuclear medicine technology, 2002 - Soc Nuclear Med
PET has emerged as a powerful diagnostic tool for the evaluation of cancer patients.
Currently, most of these studies are performed with the glucose analog 18F-FDG, which has …